Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2021-2027

Global Parkinson's Disease Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sinemet-CR
1.2.3 Trastal
1.2.4 Madopar
1.2.5 COMT Inhibitor
1.2.6 Other
1.3 Market by Application
1.3.1 Global Parkinson's Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Under 40 Years Old
1.3.3 40-65 Years Old
1.3.4 Above 65 Years Old
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Parkinson's Disease Therapeutics Market Perspective (2016-2027)
2.2 Parkinson's Disease Therapeutics Growth Trends by Regions
2.2.1 Parkinson's Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Parkinson's Disease Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Parkinson's Disease Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Parkinson's Disease Therapeutics Industry Dynamic
2.3.1 Parkinson's Disease Therapeutics Market Trends
2.3.2 Parkinson's Disease Therapeutics Market Drivers
2.3.3 Parkinson's Disease Therapeutics Market Challenges
2.3.4 Parkinson's Disease Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Parkinson's Disease Therapeutics Players by Revenue
3.1.1 Global Top Parkinson's Disease Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Parkinson's Disease Therapeutics Revenue
3.4 Global Parkinson's Disease Therapeutics Market Concentration Ratio
3.4.1 Global Parkinson's Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Parkinson's Disease Therapeutics Revenue in 2020
3.5 Parkinson's Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Parkinson's Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Parkinson's Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Parkinson's Disease Therapeutics Breakdown Data by Type
4.1 Global Parkinson's Disease Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2022-2027)
5 Parkinson's Disease Therapeutics Breakdown Data by Application
5.1 Global Parkinson's Disease Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Parkinson's Disease Therapeutics Market Size (2016-2027)
6.2 North America Parkinson's Disease Therapeutics Market Size by Type
6.2.1 North America Parkinson's Disease Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Parkinson's Disease Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Parkinson's Disease Therapeutics Market Size by Type (2016-2027)
6.3 North America Parkinson's Disease Therapeutics Market Size by Application
6.3.1 North America Parkinson's Disease Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Parkinson's Disease Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Parkinson's Disease Therapeutics Market Size by Application (2016-2027)
6.4 North America Parkinson's Disease Therapeutics Market Size by Country
6.4.1 North America Parkinson's Disease Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Parkinson's Disease Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Parkinson's Disease Therapeutics Market Size (2016-2027)
7.2 Europe Parkinson's Disease Therapeutics Market Size by Type
7.2.1 Europe Parkinson's Disease Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Parkinson's Disease Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Parkinson's Disease Therapeutics Market Size by Type (2016-2027)
7.3 Europe Parkinson's Disease Therapeutics Market Size by Application
7.3.1 Europe Parkinson's Disease Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Parkinson's Disease Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Parkinson's Disease Therapeutics Market Size by Application (2016-2027)
7.4 Europe Parkinson's Disease Therapeutics Market Size by Country
7.4.1 Europe Parkinson's Disease Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Parkinson's Disease Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Parkinson's Disease Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type
8.2.1 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application
8.3.1 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region
8.4.1 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Parkinson's Disease Therapeutics Market Size (2016-2027)
9.2 Latin America Parkinson's Disease Therapeutics Market Size by Type
9.2.1 Latin America Parkinson's Disease Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Parkinson's Disease Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Parkinson's Disease Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Parkinson's Disease Therapeutics Market Size by Application
9.3.1 Latin America Parkinson's Disease Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Parkinson's Disease Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Parkinson's Disease Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Parkinson's Disease Therapeutics Market Size by Country
9.4.1 Latin America Parkinson's Disease Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Parkinson's Disease Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type
10.2.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application
10.3.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country
10.4.1 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Parkinson's Disease Therapeutics Introduction
11.1.4 Merck Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Akorn
11.2.1 Akorn Company Details
11.2.2 Akorn Business Overview
11.2.3 Akorn Parkinson's Disease Therapeutics Introduction
11.2.4 Akorn Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.2.5 Akorn Recent Development
11.3 GSK
11.3.1 GSK Company Details
11.3.2 GSK Business Overview
11.3.3 GSK Parkinson's Disease Therapeutics Introduction
11.3.4 GSK Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.3.5 GSK Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Parkinson's Disease Therapeutics Introduction
11.4.4 Novartis Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Introduction
11.5.4 Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Company Details
11.6.2 Teva Pharmaceutical Business Overview
11.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Introduction
11.6.4 Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.6.5 Teva Pharmaceutical Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Parkinson's Disease Therapeutics Introduction
11.7.4 Abbvie Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.7.5 Abbvie Recent Development
11.8 Kyowa Hakko Kirin Pharma
11.8.1 Kyowa Hakko Kirin Pharma Company Details
11.8.2 Kyowa Hakko Kirin Pharma Business Overview
11.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Introduction
11.8.4 Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.8.5 Kyowa Hakko Kirin Pharma Recent Development
11.9 Astellas Pharma
11.9.1 Astellas Pharma Company Details
11.9.2 Astellas Pharma Business Overview
11.9.3 Astellas Pharma Parkinson's Disease Therapeutics Introduction
11.9.4 Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.9.5 Astellas Pharma Recent Development
11.10 Roche
11.10.1 Roche Company Details
11.10.2 Roche Business Overview
11.10.3 Roche Parkinson's Disease Therapeutics Introduction
11.10.4 Roche Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.10.5 Roche Recent Development
11.11 H.Lundbeck
11.11.1 H.Lundbeck Company Details
11.11.2 H.Lundbeck Business Overview
11.11.3 H.Lundbeck Parkinson's Disease Therapeutics Introduction
11.11.4 H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.11.5 H.Lundbeck Recent Development
11.12 Bausch Health
11.12.1 Bausch Health Company Details
11.12.2 Bausch Health Business Overview
11.12.3 Bausch Health Parkinson's Disease Therapeutics Introduction
11.12.4 Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.12.5 Bausch Health Recent Development
11.13 Apokyn
11.13.1 Apokyn Company Details
11.13.2 Apokyn Business Overview
11.13.3 Apokyn Parkinson's Disease Therapeutics Introduction
11.13.4 Apokyn Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.13.5 Apokyn Recent Development
11.14 Orion
11.14.1 Orion Company Details
11.14.2 Orion Business Overview
11.14.3 Orion Parkinson's Disease Therapeutics Introduction
11.14.4 Orion Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.14.5 Orion Recent Development
11.15 Stada Arzneimittel
11.15.1 Stada Arzneimittel Company Details
11.15.2 Stada Arzneimittel Business Overview
11.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Introduction
11.15.4 Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.15.5 Stada Arzneimittel Recent Development
11.16 US WorldMeds
11.16.1 US WorldMeds Company Details
11.16.2 US WorldMeds Business Overview
11.16.3 US WorldMeds Parkinson's Disease Therapeutics Introduction
11.16.4 US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.16.5 US WorldMeds Recent Development
11.17 Desitin Arzneimittel
11.17.1 Desitin Arzneimittel Company Details
11.17.2 Desitin Arzneimittel Business Overview
11.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Introduction
11.17.4 Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.17.5 Desitin Arzneimittel Recent Development
11.18 Endo Pharmaceuticals
11.18.1 Endo Pharmaceuticals Company Details
11.18.2 Endo Pharmaceuticals Business Overview
11.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Introduction
11.18.4 Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2016-2021)
11.18.5 Endo Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Parkinson's Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Sinemet-CR
Table 3. Key Players of Trastal
Table 4. Key Players of Madopar
Table 5. Key Players of COMT Inhibitor
Table 6. Key Players of Other
Table 7. Global Parkinson's Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Parkinson's Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Parkinson's Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Parkinson's Disease Therapeutics Market Share by Regions (2016-2021)
Table 11. Global Parkinson's Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Parkinson's Disease Therapeutics Market Share by Regions (2022-2027)
Table 13. Parkinson's Disease Therapeutics Market Trends
Table 14. Parkinson's Disease Therapeutics Market Drivers
Table 15. Parkinson's Disease Therapeutics Market Challenges
Table 16. Parkinson's Disease Therapeutics Market Restraints
Table 17. Global Parkinson's Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Parkinson's Disease Therapeutics Market Share by Players (2016-2021)
Table 19. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Therapeutics as of 2020)
Table 20. Ranking of Global Top Parkinson's Disease Therapeutics Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Parkinson's Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Parkinson's Disease Therapeutics Product Solution and Service
Table 24. Date of Enter into Parkinson's Disease Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2016-2021)
Table 28. Global Parkinson's Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Parkinson's Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2016-2021)
Table 32. Global Parkinson's Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Parkinson's Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Parkinson's Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Parkinson's Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Parkinson's Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Parkinson's Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Parkinson's Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Parkinson's Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Parkinson's Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 64. Merck Company Details
Table 65. Merck Business Overview
Table 66. Merck Parkinson's Disease Therapeutics Product
Table 67. Merck Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 68. Merck Recent Development
Table 69. Akorn Company Details
Table 70. Akorn Business Overview
Table 71. Akorn Parkinson's Disease Therapeutics Product
Table 72. Akorn Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 73. Akorn Recent Development
Table 74. GSK Company Details
Table 75. GSK Business Overview
Table 76. GSK Parkinson's Disease Therapeutics Product
Table 77. GSK Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 78. GSK Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Parkinson's Disease Therapeutics Product
Table 82. Novartis Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Boehringer Ingelheim Company Details
Table 85. Boehringer Ingelheim Business Overview
Table 86. Boehringer Ingelheim Parkinson's Disease Therapeutics Product
Table 87. Boehringer Ingelheim Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 88. Boehringer Ingelheim Recent Development
Table 89. Teva Pharmaceutical Company Details
Table 90. Teva Pharmaceutical Business Overview
Table 91. Teva Pharmaceutical Parkinson's Disease Therapeutics Product
Table 92. Teva Pharmaceutical Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 93. Teva Pharmaceutical Recent Development
Table 94. Abbvie Company Details
Table 95. Abbvie Business Overview
Table 96. Abbvie Parkinson's Disease Therapeutics Product
Table 97. Abbvie Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 98. Abbvie Recent Development
Table 99. Kyowa Hakko Kirin Pharma Company Details
Table 100. Kyowa Hakko Kirin Pharma Business Overview
Table 101. Kyowa Hakko Kirin Pharma Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 102. Kyowa Hakko Kirin Pharma Recent Development
Table 103. Astellas Pharma Company Details
Table 104. Astellas Pharma Business Overview
Table 105. Astellas Pharma Parkinson's Disease Therapeutics Product
Table 106. Astellas Pharma Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 107. Astellas Pharma Recent Development
Table 108. Roche Company Details
Table 109. Roche Business Overview
Table 110. Roche Parkinson's Disease Therapeutics Product
Table 111. Roche Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 112. Roche Recent Development
Table 113. H.Lundbeck Company Details
Table 114. H.Lundbeck Business Overview
Table 115. H.Lundbeck Parkinson's Disease Therapeutics Product
Table 116. H.Lundbeck Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 117. H.Lundbeck Recent Development
Table 118. Bausch Health Company Details
Table 119. Bausch Health Business Overview
Table 120. Bausch Health Parkinson's Disease Therapeutics Product
Table 121. Bausch Health Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 122. Bausch Health Recent Development
Table 123. Apokyn Company Details
Table 124. Apokyn Business Overview
Table 125. Apokyn Parkinson's Disease Therapeutics Product
Table 126. Apokyn Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 127. Apokyn Recent Development
Table 128. Orion Company Details
Table 129. Orion Business Overview
Table 130. Orion Parkinson's Disease Therapeutics Product
Table 131. Orion Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 132. Orion Recent Development
Table 133. Stada Arzneimittel Company Details
Table 134. Stada Arzneimittel Business Overview
Table 135. Stada Arzneimittel Parkinson's Disease Therapeutics Product
Table 136. Stada Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 137. Stada Arzneimittel Recent Development
Table 138. US WorldMeds Company Details
Table 139. US WorldMeds Business Overview
Table 140. US WorldMeds Parkinson's Disease Therapeutics Product
Table 141. US WorldMeds Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 142. US WorldMeds Recent Development
Table 143. Desitin Arzneimittel Company Details
Table 144. Desitin Arzneimittel Business Overview
Table 145. Desitin Arzneimittel Parkinson's Disease Therapeutics Product
Table 146. Desitin Arzneimittel Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 147. Desitin Arzneimittel Recent Development
Table 148. Endo Pharmaceuticals Company Details
Table 149. Endo Pharmaceuticals Business Overview
Table 150. Endo Pharmaceuticals Parkinson's Disease Therapeutics Product
Table 151. Endo Pharmaceuticals Revenue in Parkinson's Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 152. Endo Pharmaceuticals Recent Development
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Parkinson's Disease Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Sinemet-CR Features
Figure 3. Trastal Features
Figure 4. Madopar Features
Figure 5. COMT Inhibitor Features
Figure 6. Other Features
Figure 7. Global Parkinson's Disease Therapeutics Market Share by Application: 2020 VS 2027
Figure 8. Under 40 Years Old Case Studies
Figure 9. 40-65 Years Old Case Studies
Figure 10. Above 65 Years Old Case Studies
Figure 11. Parkinson's Disease Therapeutics Report Years Considered
Figure 12. Global Parkinson's Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Parkinson's Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Parkinson's Disease Therapeutics Market Share by Regions: 2020 VS 2027
Figure 15. Global Parkinson's Disease Therapeutics Market Share by Regions (2022-2027)
Figure 16. Global Parkinson's Disease Therapeutics Market Share by Players in 2020
Figure 17. Global Top Parkinson's Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Parkinson's Disease Therapeutics as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Parkinson's Disease Therapeutics Revenue in 2020
Figure 19. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2016-2021)
Figure 20. Global Parkinson's Disease Therapeutics Revenue Market Share by Type (2022-2027)
Figure 21. North America Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 23. North America Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 24. North America Parkinson's Disease Therapeutics Market Share by Country (2016-2027)
Figure 25. United States Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 29. Europe Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 30. Europe Parkinson's Disease Therapeutics Market Share by Country (2016-2027)
Figure 31. Germany Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Parkinson's Disease Therapeutics Market Share by Region (2016-2027)
Figure 41. China Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 49. Latin America Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 50. Latin America Parkinson's Disease Therapeutics Market Share by Country (2016-2027)
Figure 51. Mexico Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Parkinson's Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Parkinson's Disease Therapeutics Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Parkinson's Disease Therapeutics Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Parkinson's Disease Therapeutics Market Share by Country (2016-2027)
Figure 57. Turkey Parkinson's Disease Therapeu

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Parkinson's Disease Therapeutics Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......

Global Amantadine Hydrochloride Market Insights, Forecast to 2029

Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......

Global Rasagiline Tablet Market Insights, Forecast to 2029

Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107

Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......

Global Parkinsons Disease Drug Market Insights, Forecast to 2029

Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113

Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......

Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028

Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109

Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......

Global Amantadine Hydrochloride Market Research Report 2023

Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98

Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......

Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028

Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159

Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs